Literature DB >> 18849979

Ubiquitylation of the COMPASS component Swd2 links H2B ubiquitylation to H3K4 trimethylation.

Adeline Vitaliano-Prunier1, Alexandra Menant, Maria Hobeika, Vincent Géli, Carole Gwizdek, Catherine Dargemont.   

Abstract

Mono-ubiquitylation of histone H2B correlates with transcriptional activation and is required for di- and trimethylation at Lys 4 on the histone H3 tail (H3K4) by the SET1/COMPASS methyltransferase complex through a poorly characterized trans-tail pathway. Here we show that mono-ubiquitylation of histone H2B promotes ubiquitylation at Lys 68 and Lys 69 of Swd2, the essential component of SET1/COMPASS in Saccharomyces cerevisiae. We found that Rad6/Bre1 ubiquitylation enzymes responsible for H2B ubiquitylation also participate directly in Swd2 modification. Preventing Swd2 or H2B ubiquitylation did not affect Set1 stability, interaction of Swd2 with Set1 or the ability of Swd2 to interact with chromatin. However, we found that mutation of Lys 68 and Lys 69 of Swd2 markedly reduced trimethylation, and to a lesser extent dimethylation, of H3K4 at the 5'-end of transcribing genes without affecting monomethylation. This effect results from the ability of Swd2 ubiquitylation to control recruitment of Spp1, a COMPASS subunit necessary for trimethylation. Our results further indicate that Swd2 is a major H3-binding component of COMPASS. Swd2 thus represents a key factor that mediates crosstalk between H2B ubiquitylation and H3K4 trimethylation on chromatin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18849979     DOI: 10.1038/ncb1796

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  65 in total

Review 1.  The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis.

Authors:  Ali Shilatifard
Journal:  Annu Rev Biochem       Date:  2012       Impact factor: 23.643

Review 2.  Ubiquitin and proteasomes in transcription.

Authors:  Fuqiang Geng; Sabine Wenzel; William P Tansey
Journal:  Annu Rev Biochem       Date:  2012-03-08       Impact factor: 23.643

Review 3.  Shaping the landscape: mechanistic consequences of ubiquitin modification of chromatin.

Authors:  Sigurd Braun; Hiten D Madhani
Journal:  EMBO Rep       Date:  2012-06-29       Impact factor: 8.807

Review 4.  Histone H2B ubiquitination and beyond: Regulation of nucleosome stability, chromatin dynamics and the trans-histone H3 methylation.

Authors:  Mahesh B Chandrasekharan; Fu Huang; Zu-Wen Sun
Journal:  Epigenetics       Date:  2010-08-16       Impact factor: 4.528

5.  Novel trans-tail regulation of H2B ubiquitylation and H3K4 methylation by the N terminus of histone H2A.

Authors:  Suting Zheng; John J Wyrick; Joseph C Reese
Journal:  Mol Cell Biol       Date:  2010-05-24       Impact factor: 4.272

Review 6.  SET for life: biochemical activities and biological functions of SET domain-containing proteins.

Authors:  Hans-Martin Herz; Alexander Garruss; Ali Shilatifard
Journal:  Trends Biochem Sci       Date:  2013-10-20       Impact factor: 13.807

7.  Chromatin signaling to kinetochores: transregulation of Dam1 methylation by histone H2B ubiquitination.

Authors:  John A Latham; Renée J Chosed; Shanzhi Wang; Sharon Y R Dent
Journal:  Cell       Date:  2011-09-02       Impact factor: 41.582

Review 8.  Structural basis for H3K4 trimethylation by yeast Set1/COMPASS.

Authors:  Yoh-Hei Takahashi; Ali Shilatifard
Journal:  Adv Enzyme Regul       Date:  2009-12-18

9.  ASH2L regulates ubiquitylation signaling to MLL: trans-regulation of H3 K4 methylation in higher eukaryotes.

Authors:  Lipeng Wu; Shirley Y Lee; Bo Zhou; Uyen T T Nguyen; Tom W Muir; Song Tan; Yali Dou
Journal:  Mol Cell       Date:  2013-02-28       Impact factor: 17.970

10.  The n-SET domain of Set1 regulates H2B ubiquitylation-dependent H3K4 methylation.

Authors:  Jaehoon Kim; Jung-Ae Kim; Robert K McGinty; Uyen T T Nguyen; Tom W Muir; C David Allis; Robert G Roeder
Journal:  Mol Cell       Date:  2013-02-28       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.